Singapore approves Gilead's remdesivir for COVID-19 treatment

Reuters

10 Jun 2020 0 shares 1 views

Singapore approves Gilead's remdesivir for COVID-19 treatment

Reuters

Published 10 Jun 2020

Singapore's Health Sciences Authority said on Wednesday it granted conditional approval for Gilead Sciences Inc's antiviral drug remdesivir for the treatment of some patients with COVID-19 infection.

Full Article

Gilead to charge governments $2,340 for Covid-19 treatment remdesivir

FT.com 29 Jun 2020

US drugmaker releases proposed pricing for one of most promising coronavirus medicines

Israel approves remdesivir drug for COVID-19 treatment
Reuters 16 Jun 2020
India's Zydus Cadila to make Gilead's potential COVID-19 drug remdesivir
Reuters 12 Jun 2020
Singapore approves remdesivir drug for emergency COVID-19 treatment
Reuters 10 Jun 2020
EU watchdog aims for speedy approval of remdesivir as COVID-19 treatment
Reuters 08 Jun 2020

More coverage

EU watchdog assessing Gilead application for COVID-19 treatment

Reuters 08 Jun 2020

The European health regulator said on Monday it had received an application from U.S. drugmaker Gilead Sciences Inc for approval of..

Gilead's remdesivir could see $7 billion in annual sales on stockpiling boost: analyst
Reuters 03 Jun 2020
South Korea approves import of anti-viral drug remdesivir for coronavirus treatment
Reuters 03 Jun 2020
Gilead's next step on coronavirus: inhaled remdesivir, other easier-to-use versions
Reuters 02 Jun 2020
Gilead's remdesivir shows modest improvement in moderate COVID-19 patients
Reuters 01 Jun 2020

Singapore approves Gilead's remdesivir for COVID-19 treatment

Singapore approves Gilead's remdesivir for COVID-19 treatment

You might like

Related news coverage

Gilead to charge governments $2,340 for Covid-19 treatment remdesivir

Advertisement

More coverage

EU watchdog assessing Gilead application for COVID-19 treatment